New Synthetic RNA Co...
MBV Ltd and MERCK KG...
5th January 2021 Product update: rapidmicrobiology staff writer
The Role of LIMS in Supporting ISO 17025 Accreditation (Whitepaper)
Autoscribe Informatics has released a new white paper examining the role of a Laboratory Information Management System (LIMS) in supporting ISO17025 accreditation. The white paper explores the ways in which a Laboratory Information Management System (LIMS) can play a key role in achieving, maintaining, and benefiting from ISO17025 accreditation.
ISO/IEC17025:2017 is the international standard for testing and calibration laboratories. A key element of the standard is that it requires laboratories to demonstrate that they operate competently and can generate valid results. The latest version of the standard (2017) encourages a risk-based approach and requires organizations to assess and minimize those risks.
Key to this is the management of the laboratory process, the management of laboratory resources and the management of data that exists in, or is created by, the laboratory. By its nature, LIMS is tightly linked to these key areas. It is therefore important to understand how LIMS can help you minimize these risks.
In this white paper you will learn about:
- Managing sample handling and testing processes in the context of ISO17025
- Resources requirements including personnel, facilities, and equipment
- Process requirements including logging requests, selection of methods, the sampling process, validation and reporting of results, and managing non-conforming work
- Relevant section references to find the source information in ISO17025
An ideal source of reference information, the white paper is relevant to laboratory and quality management teams who need to demonstrate competence and compliance with the ISO17025 quality management system.
The white paper can be downloaded from here.
Tags:
Date Published: 5th January 2021
Source article link: View
Note: This content has been edited by a rapidmicrobiology staff writer for style and content.
New Synthetic RNA Control for
MBV Ltd and MERCK KGaA